1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1–38. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4909a1.htm. Accessed April 9, 2007
2. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362–366
3. Centers for Disease Control and Prevention. Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53:177–178. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5308a5.htm. Accessed April 9, 2007
4. Centers for Disease Control and Prevention. Notice to readers: decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783–784. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5036a3.htm. Accessed April 9, 2007
5. Centers for Disease Control and Prevention. Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage—Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50:1140–1142. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5050a4.htm. Accessed April 9, 2007